scholarly article | Q13442814 |
P50 | author | Steven L. Spitalnik | Q46735983 |
Lisbeth A. Welniak | Q104889873 | ||
P2093 | author name string | Dana V Devine | |
Walter H Dzik | |||
Naomi L C Luban | |||
Nareg H Roubinian | |||
Daryl J Kor | |||
Anne F Eder | |||
Cassandra D Josephson | |||
Darrell Triulzi | |||
Simone Glynn | |||
Shimian Zou | |||
Traci Mondoro | |||
Terry Gernsheimer | |||
State of the Science in Transfusion Medicine Working Groups | |||
P2860 | cites work | Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion | Q24200170 |
Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds | Q33156298 | ||
Factors associated with fainting: before, during and after whole blood donation | Q33159992 | ||
A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation | Q33376798 | ||
Novel clearance mechanisms of platelets | Q33391541 | ||
A survey of transfusion practices in pediatric hematopoietic stem cell transplant patients | Q33404274 | ||
Bleeding and coagulopathies in critical care | Q33413516 | ||
Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). | Q33415825 | ||
Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation | Q33418906 | ||
Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease | Q34067039 | ||
Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery | Q34234330 | ||
Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis | Q34413187 | ||
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions | Q34564925 | ||
Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries | Q34579964 | ||
Blood management: transfusion medicine comes of age. | Q34652252 | ||
Concepts of blood transfusion in adults | Q34652259 | ||
Large-scale production of red blood cells from stem cells: what are the technical challenges ahead? | Q34658807 | ||
Resuscitation and transfusion principles for traumatic hemorrhagic shock | Q35174893 | ||
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial | Q35219638 | ||
Transfusion trigger: when to transfuse? | Q35804524 | ||
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management | Q36106307 | ||
Effect of processing and storage on red blood cell function in vivo | Q36115205 | ||
Bleeding in cardiac surgery: its prevention and treatment--an evidence-based review | Q36181650 | ||
Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study | Q36745315 | ||
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease | Q36878553 | ||
Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy | Q37060694 | ||
Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial | Q37142033 | ||
Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). | Q37464134 | ||
Risk-based decision-making for blood safety: preliminary report of a consensus conference | Q37903892 | ||
Platelet storage and transfusions: new concerns associated with an old therapy | Q38015853 | ||
Challenges and promises for the development of donor-independent platelet transfusions | Q38074224 | ||
Platelet transfusion: a systematic review of the clinical evidence | Q38267183 | ||
Deriving blood stem cells from pluripotent stem cells for research and therapy | Q38279078 | ||
Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands | Q38332335 | ||
Bleeding during critical illness: a prospective cohort study using a new measurement tool. | Q40180744 | ||
Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery | Q40601451 | ||
Diagnostic randomized controlled trials: the final frontier | Q41231422 | ||
Cultured blood versus donated blood: long-run perspectives of the economy of blood | Q41653001 | ||
Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss | Q43700338 | ||
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma | Q45343282 | ||
Impact of ABO-Identical vs ABO-Compatible Nonidentical Plasma Transfusion in Trauma Patients | Q46778443 | ||
Physiologic transfusion triggers | Q47573609 | ||
An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). | Q48085790 | ||
Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses. | Q50460022 | ||
Additive solution-7 reduces the red blood cell cold storage lesion. | Q50460076 | ||
The use of lyophilized plasma in a severe multi-injury pig model. | Q50496754 | ||
Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. | Q50646739 | ||
Menopausal status affects the susceptibility of stored RBCs to mechanical stress. | Q51476501 | ||
Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. | Q53205612 | ||
Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma | Q57579836 | ||
Transfusion of ABO-mismatched platelets leads to early platelet refractoriness | Q68534410 | ||
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease | Q68545154 | ||
Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathy | Q84190075 | ||
Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients | Q84853003 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2282-2290 | |
P577 | publication date | 2015-08-10 | |
P1433 | published in | Transfusion | Q15758500 |
P1476 | title | 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium | |
P478 | volume | 55 |
Q47610507 | 2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules. |
Q36821022 | A Comparative Study of the Effect of Leukoreduction and Pre-storage Leukodepletion on Red Blood Cells during Storage |
Q90316062 | A rose is a rose is a rose, or not |
Q39179984 | Bio-inspired nanomedicine strategies for artificial blood components |
Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
Q46460311 | Citrate metabolism in red blood cells stored in additive solution-3. |
Q88706622 | Development, validation, and potential applications of biotinylated red blood cells for posttransfusion kinetics and other physiological studies: evidenced-based analysis and recommendations |
Q38963866 | Do we need [more] clinical trials in Transfusion Medicine and Hemotherapy? |
Q92654817 | Electron paramagnetic resonance oximetry as a novel approach to monitor the effectiveness and quality of red blood cell transfusions |
Q33689210 | Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays |
Q57794948 | Heterogeneity of blood processing and storage additives in different centers impacts stored red blood cell metabolism as much as storage time: lessons from REDS-III-Omics |
Q61808594 | Hitchhiker's guide to the red blood cell storage lesion |
Q38739597 | Hitchhiker's guide to the red cell storage galaxy: Omics technologies and the quality issue |
Q49305174 | Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage |
Q33437439 | In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice |
Q38667980 | Metabolomics in transfusion medicine |
Q37679821 | Omics markers of the red cell storage lesion and metabolic linkage |
Q55220761 | Pediatric and Neonatal Transfusion Medicine: A Roadmap for Research. |
Q91067835 | Plasma for direct therapeutic use, for today and tomorrow: A short critical overview |
Q50213413 | Red blood cell metabolic responses to refrigerated storage, rejuvenation, and frozen storage |
Q54963478 | Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study. |
Q50265769 | Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology |
Q90480268 | The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia |
Q39185581 | The intensive care medicine clinical research agenda in paediatrics. |
Q38815368 | Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness |